A new Diabetologia study shows that insulin-resistant visceral adipose tissue overproduces 2-AG and anandamide, while recent work suggests insulin can also increase CB1 receptor stability. Together, these findings raise a testable question: can metabolic dysfunction amplify CB1 signalling by increasing both endogenous ligand production and receptor abundance?
